Summaries of landmark trials and emerging evidence in retinal medicine — distilled for the busy clinician with critical appraisal.
Summaries of landmark trials and emerging evidence in retinal medicine — distilled for the busy clinician with critical appraisal. Content is in development — follow on social media for launch updates.
Follow on YouTube16-week interval dosing in diabetic macular oedema — what the results mean for your injection clinic.
Key takeaways from this year's European retinal meeting — AI, gene therapy, and emerging anti-VEGF agents.
A meta-analysis digest comparing long-term visual outcomes and injection burden across the two dominant treatment strategies.